Anti-Dumping Policy and its Effect on Indian Pharmaceutical Sector

被引：0

作者：

Srivastava, Astha ^{[1
]}

Sinha, Shivangi ^{[1
]}

机构：

[1] Bharati Vidyapeeth, New Law Coll, Pune, Maharashtra, India

来源：

INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES | 2019年 / 8卷 / 08期

关键词：

Anti-dumping; GATT; Competition Act; Drug pricing control order; Predatory pricing; TOXOPLASMA-GONDII;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Trade policy regimes are changing and growing towards a protectionist attitude. Liberal trade policies might harm the trade and commerce of a country. Therefore GATT contains some measures for the member countries to impose higher protection against imports. One of these measures is known as anti-dumping. When a country sends its products to another country and sells it at less than the normal value it is known as dumping. Dumping results in harming the established market practices and anti-competitive activities. Significance Statement: The paper aims at studying anti-dumping policies prevalent in our country and how dumping is affecting the pharmaceutical sector of the country.

引用

页码：87 / 90

页数：4